Molecular Diagnostics
Gene Testing Patents Block Competition, Slow Innovation
Exclusive licenses to gene patents, most of which in the United States are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to trigger the development of new technologies for gauging disease risk, according to researchers. More...13 May 2010
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Hemodynamic System Monitor
OptoMonitor
In Other News
Specific Proteomic Profiles Predict Outcomes in Lung Cancer Patients
MS Markers Identified Years Before Disease Is Diagnosed
Prognostic Test Monitors Postoperative Prostate Cancer Patients
Assay Identifies Patients with Low Tumor Expression of hENT1
First X-Linked Mental Retardation Diagnostic Panel Developed
DNA Assays Monitor MS Activity and Treatment Response
Gene Expression Test Effectively Predicts Prostate Cancer Recurrence
Nine Types of GI Infections Rapidly and Simultaneously Detected
Over Thirty Nucleic Acid-Based Diagnostic Kits Released
Laboratory Blood Test Validated for Fragile X Syndrome
DNA-Probe Rapidly Screens for MRSA
Genomic Sequencing Method Speeds Analysis for Individualized Medicine for Oral Cancer
Diagnostic Test Developed to Predict Prostate Cancer Recurrence
Automating Viral RNA Genotyping System Streamlines PCR Workflow
Urinary Protein Testing May Help Diagnose Kidney Damage from Lupus
Genetic Link Found Between Mammographic Density and Breast Cancer
Fungal Infection Test Measures Gene Response
Simple DNA Test Could Identify the Risk of Inherited Diseases
Laboratory Medicine and Nosocomial Infections: Coping with Clostridium difficile
Genome Sequencing Study Finds Clues to Determining Causes of Lethal Epidemics
Laboratory Medicine and Nosocomial Infections: Dealing with MRSA
Laboratory Medicine and Nosocomial Infections: the Present
DNA Databank Provides Access on One of the Larges Genetic Repositories
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
